As climate change brings more intense heat waves, scientists are trying to understand how certain medications interact with ...

Finally, a recent study suggested that although prasugrel significantly reduces thrombotic events in patients with ACS undergoing PCI because of its superior antiplatelet potency compared with ...

The effectiveness of prophylactic antiplatelet agents to prevent HAT has not been studied in depth, despite the clinical importance of this postoperative complication. Vivarelli and colleagues ...

What’s more, onions are in the allium family of vegetables, which means they contain antiplatelet agents that can prevent cardiovascular disease. A 2012 study found that when raw onions were heated in ...

Vitamin E may relieve menstrual pain - (https://endometriosis.org/news/research/vitamin-e-may-relieve-menstrual-pain/) ...

A recent trial found that patients with acute coronary syndrome (ACS) who have undergone percutaneous coronary intervention ...

Rageh Omaar recently suffered a ‘mini stroke’ live on air. But what is it, who is at risk – and is it serious?

Opens in a new tab or window ATLANTA -- In select patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndromes who were event-free for 1 month on dual antiplatelet ...

A second antiplatelet, such as ticagrelor, is often offered in combination with aspirin for a defined period of time, generally up to 12 months. There have been many reports of people continuing on ...

Researchers have found that intravenous tirofiban, administered within 24 hours of stroke onset, decreases the risk of early ...

Expert Rev Clin Pharmacol. 2012;5(3):319-336. Overall, the PAR-1 antagonists are potent antiplatelet agents with predictable metabolic and pharmacodynamic profiles; however, their clinical ...

A second antiplatelet, such as ticagrelor, is often offered in combination with aspirin for a defined period of time, generally up to 12 months. There have been many reports of people continuing on ...